Arcellx (ACLX) Research & Development (2021 - 2025)

Arcellx's quarterly Research & Development came in at $34.1 million in Q4 2025, down 23.64% year-on-year from $44.6 million in Q4 2024, and down 2.83% quarter-over-quarter from $35.1 million in Q3 2025.

Arcellx has reported Research & Development for 5 years, with the latest figure at $34.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 23.64% year-over-year to $34.1 million; the trailing twelve-month figure through Dec 2025 stood at $157.6 million (changed 0.33% YoY), and the FY2025 full-year result was $157.6 million, changed 0.33% from the prior year.
  • Research & Development for Q4 2025 stood at $34.1 million, down from $35.1 million in the prior quarter.
  • The five-year high for Research & Development was $83.5 million in Q3 2022, with the low at $8.5 million in Q1 2021.
  • Average Research & Development over 5 years is $32.2 million, with a median of $32.6 million recorded in 2023.
  • Year-over-year, Research & Development surged 577.27% in 2022 and slumped 47.52% in 2023.
  • Tracing ACLX's Research & Development over 5 years: stood at $13.4 million in 2021, then surged by 93.69% to $25.9 million in 2022, then grew by 10.95% to $28.8 million in 2023, then jumped by 55.12% to $44.6 million in 2024, then slipped by 23.64% to $34.1 million in 2025.
  • The last three Research & Development figures came in at $34.1 million (Q4 2025), $35.1 million (Q3 2025), and $37.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 626,092.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.32 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -101.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 1.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 961.60 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -2.30 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.54 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 364.87 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 34.10 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 34.10 Mn
Sep 30, 2025 35.09 Mn
Jun 30, 2025 37.63 Mn
Mar 31, 2025 50.80 Mn
Dec 31, 2024 44.65 Mn
Sep 30, 2024 39.17 Mn
Jun 30, 2024 40.95 Mn
Mar 31, 2024 32.32 Mn
Dec 31, 2023 28.78 Mn
Sep 30, 2023 43.81 Mn
Jun 30, 2023 28.33 Mn
Mar 31, 2023 32.93 Mn
Dec 31, 2022 25.94 Mn
Sep 30, 2022 83.47 Mn
Jun 30, 2022 22.08 Mn
Mar 31, 2022 18.06 Mn
Dec 31, 2021 13.39 Mn
Sep 30, 2021 12.33 Mn
Jun 30, 2021 12.64 Mn
Mar 31, 2021 8.52 Mn